Drug Administration ScheduleDose-Response Relationship, DrugAbnormalities, MultipleChromosome AberrationsCongenital AbnormalitiesTime FactorsChromosome DisordersRadiation DosageLethal Dose 50KaryotypingEye AbnormalitiesMagnetic Resonance ImagingAdministration, OralBrainTreatment OutcomePregnancyRadiometryDisease Models, AnimalCardiovascular AbnormalitiesCraniofacial AbnormalitiesSyndromePhenotypeMutationDose-Response Relationship, RadiationDouble-Blind MethodProspective StudiesRetrospective StudiesSkin AbnormalitiesUrogenital AbnormalitiesInfant, NewbornDose FractionationRadiotherapy DosageTrisomyTomography, X-Ray ComputedMusculoskeletal AbnormalitiesIn Situ Hybridization, FluorescenceInjections, IntravenousFollow-Up StudiesElectrocardiographyTooth AbnormalitiesArea Under CurveRats, Sprague-DawleyAbnormalities, Drug-InducedInfusions, IntravenousAneuploidyAnalysis of VarianceTranslocation, GeneticSensitivity and SpecificityCase-Control StudiesLiverHalf-LifeMice, KnockoutKidneyRadiotherapy Planning, Computer-AssistedRisk FactorsSex Chromosome AberrationsSchizophreniaNeoplasmsReference ValuesBrain DiseasesAntineoplastic AgentsBody WeightPrognosisFetal DiseasesCytogenetic AnalysisMice, TransgenicDogsBlood PressurePedigreeLungDrug Therapy, CombinationDrug InteractionsRadiation InjuriesHeart Defects, CongenitalRats, WistarReproducibility of ResultsCells, CulturedHeartUltrasonography, PrenatalEchocardiographyChromosome DeletionBody BurdenMice, Mutant StrainsElectroencephalographyAcute DiseaseCytogeneticsThermoluminescent DosimetryCohort StudiesAge FactorsPredictive Value of TestsHomozygoteImage Processing, Computer-AssistedBone MarrowBehavior, AnimalPrenatal DiagnosisHeterozygoteChromosome BandingSeverity of Illness IndexBiopsyInjections, Subcutaneous